Case report · 30 Jan 2025
EditorialPublished 31 Jul 2023
Immunogenicity of Biopharmaceuticals: The Immune Response to Therapeutic Proteins
Department of Biological Sciences, National University of Califonian, Japan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A serious clinical event is when an immune response to a therapeutic protein interferes with the biopharmaceutical activity or interacts with an endogenous protein. In recent years, a lot of attention has been paid to the role that protein aggregates and particles in biopharmaceutical formulations play in mediating this immune response. Model frameworks that could reliably and dependably foresee the general immunogenicity of biopharmaceutical protein definitions would be incredibly significant. In an effort to provide this insight, a number of methods, such as in silico algorithms, in vitro tests using human leukocytes, and in vivo animal models, have been developed.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Cytokine Biology.
Case report · 30 Jan 2025
Inflammatory Diseases: Understanding, Causes, and Treatments
Perspective · 30 Jan 2025
Targeted Treatment: A Precision Approach to Healthcare
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cytokine Biology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Zheng Tay”